Postoperative Nausea and Vomiting (PONV) Market Report

Global and Region Postoperative Nausea and Vomiting (PONV) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：178
  • REPORT CODE：GMM894696
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Postoperative Nausea and Vomiting (PONV) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Postoperative Nausea and Vomiting (PONV)market, defines the market attractiveness level of Postoperative Nausea and Vomiting (PONV) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Postoperative Nausea and Vomiting (PONV) industry, describes the types of Postoperative Nausea and Vomiting (PONV) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Postoperative Nausea and Vomiting (PONV) market and the development prospects and opportunities of Postoperative Nausea and Vomiting (PONV) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Postoperative Nausea and Vomiting (PONV) market in Chapter 13.

    By Player:

    • Camurus

    • Helsinn Holding

    • Eisai

    • GlaxoSmithKline

    • Ani Pharmaceuticals

    • Merck

    • Acacia Pharma

    • Novartis

    • Sanofi

    • F Hoffmann-La Roche

    By Type:

    • Serotonin Antagonists

    • Steroids

    • Dopamine Antagonists

    • NK-1 Receptor Antagonists

    • Others

    • Non-pharmacologic Treatment

    By End-User:

    • Hospital Pharmacies

    • Online Pharmacies

    • Retail Pharmacies and Drug Stores

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Postoperative Nausea and Vomiting (PONV) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Postoperative Nausea and Vomiting (PONV) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Postoperative Nausea and Vomiting (PONV) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Postoperative Nausea and Vomiting (PONV) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Postoperative Nausea and Vomiting (PONV) Market Analysis and Outlook to 2022

    • 7.1 Global Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

    • 7.2 United States Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

    • 7.3 Europe Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

    • 7.4 China Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

    • 7.5 Japan Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

    • 7.6 India Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

    • 7.7 South Korea Postoperative Nausea and Vomiting (PONV) Consumption (2017-2022)

    8 Region and Country-wise Postoperative Nausea and Vomiting (PONV) Market Analysis and Outlook to 2028

    • 8.1 Global Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

    • 8.2 United States Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

    • 8.3 Europe Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

    • 8.4 China Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

    • 8.5 Japan Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

    • 8.6 India Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

    • 8.7 South Korea Postoperative Nausea and Vomiting (PONV) Consumption Forecast (2022-2028)

    9 Global Postoperative Nausea and Vomiting (PONV) Market Outlook by Types and Applications to 2022

    • 9.1 Global Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Serotonin Antagonists Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Steroids Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Dopamine Antagonists Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global NK-1 Receptor Antagonists Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Non-pharmacologic Treatment Consumption and Growth Rate (2017-2022)

    • 9.2 Global Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Online Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Retail Pharmacies and Drug Stores Consumption and Growth Rate (2017-2022)

    10 Global Postoperative Nausea and Vomiting (PONV) Market Outlook by Types and Applications to 2028

    • 10.1 Global Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Serotonin Antagonists Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Steroids Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Dopamine Antagonists Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global NK-1 Receptor Antagonists Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Non-pharmacologic Treatment Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Retail Pharmacies and Drug Stores Consumption Forecast and Growth Rate (2022-2028)

    11 Global Postoperative Nausea and Vomiting (PONV) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Postoperative Nausea and Vomiting (PONV) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Postoperative Nausea and Vomiting (PONV) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Postoperative Nausea and Vomiting (PONV) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Postoperative Nausea and Vomiting (PONV) Market Competitive Analysis

    • 14.1 Camurus

      • 14.1.1 Camurus Company Details

      • 14.1.2 Camurus Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Camurus Postoperative Nausea and Vomiting (PONV) Product and Service

    • 14.2 Helsinn Holding

      • 14.2.1 Helsinn Holding Company Details

      • 14.2.2 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Product and Service

    • 14.3 Eisai

      • 14.3.1 Eisai Company Details

      • 14.3.2 Eisai Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Eisai Postoperative Nausea and Vomiting (PONV) Product and Service

    • 14.4 GlaxoSmithKline

      • 14.4.1 GlaxoSmithKline Company Details

      • 14.4.2 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Product and Service

    • 14.5 Ani Pharmaceuticals

      • 14.5.1 Ani Pharmaceuticals Company Details

      • 14.5.2 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Product and Service

    • 14.6 Merck

      • 14.6.1 Merck Company Details

      • 14.6.2 Merck Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Merck Postoperative Nausea and Vomiting (PONV) Product and Service

    • 14.7 Acacia Pharma

      • 14.7.1 Acacia Pharma Company Details

      • 14.7.2 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Product and Service

    • 14.8 Novartis

      • 14.8.1 Novartis Company Details

      • 14.8.2 Novartis Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Novartis Postoperative Nausea and Vomiting (PONV) Product and Service

    • 14.9 Sanofi

      • 14.9.1 Sanofi Company Details

      • 14.9.2 Sanofi Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Sanofi Postoperative Nausea and Vomiting (PONV) Product and Service

    • 14.10 F Hoffmann-La Roche

      • 14.10.1 F Hoffmann-La Roche Company Details

      • 14.10.2 F Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 F Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Postoperative Nausea and Vomiting (PONV)

    • Figure Postoperative Nausea and Vomiting (PONV) Picture

    • Table Global Postoperative Nausea and Vomiting (PONV) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Postoperative Nausea and Vomiting (PONV) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Postoperative Nausea and Vomiting (PONV) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Postoperative Nausea and Vomiting (PONV) Consumption by Country (2017-2022)

    • Figure United States Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Table Europe Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure China Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Japan Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure India Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate (2017-2022)

    • Figure Global Postoperative Nausea and Vomiting (PONV) Consumption Forecast by Country (2022-2028)

    • Figure United States Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Postoperative Nausea and Vomiting (PONV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Serotonin Antagonists Consumption and Growth Rate (2017-2022)

    • Figure Global Steroids Consumption and Growth Rate (2017-2022)

    • Figure Global Dopamine Antagonists Consumption and Growth Rate (2017-2022)

    • Figure Global NK-1 Receptor Antagonists Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Non-pharmacologic Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacies and Drug Stores Consumption and Growth Rate (2017-2022)

    • Figure Global Serotonin Antagonists Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Steroids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dopamine Antagonists Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global NK-1 Receptor Antagonists Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-pharmacologic Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacies and Drug Stores Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Postoperative Nausea and Vomiting (PONV) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Postoperative Nausea and Vomiting (PONV) Export by Region (Top 5 Countries) (2017-2028)

    • Table Camurus (Foundation Year, Company Profile and etc.)

    • Table Camurus Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Camurus Postoperative Nausea and Vomiting (PONV) Product and Service

    • Table Helsinn Holding (Foundation Year, Company Profile and etc.)

    • Table Helsinn Holding Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Helsinn Holding Postoperative Nausea and Vomiting (PONV) Product and Service

    • Table Eisai (Foundation Year, Company Profile and etc.)

    • Table Eisai Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eisai Postoperative Nausea and Vomiting (PONV) Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Product and Service

    • Table Ani Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Postoperative Nausea and Vomiting (PONV) Product and Service

    • Table Acacia Pharma (Foundation Year, Company Profile and etc.)

    • Table Acacia Pharma Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Acacia Pharma Postoperative Nausea and Vomiting (PONV) Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Postoperative Nausea and Vomiting (PONV) Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Postoperative Nausea and Vomiting (PONV) Product and Service

    • Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US